Solid Biosciences (SLDB) Return on Capital Employed Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -494.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -649.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4,853.00 |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | -1,570.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,570.00 |
| Dec 31, 2025 | -2,828.00 |
| Sep 30, 2025 | -1,619.00 |
| Jun 30, 2025 | -600.00 |
| Mar 31, 2025 | -1,944.00 |
| Dec 31, 2024 | -4,303.00 |
| Sep 30, 2024 | -2,455.00 |
| Jun 30, 2024 | -1,354.00 |
| Mar 31, 2024 | -1,329.00 |
| Dec 31, 2023 | 4,363.00 |
| Sep 30, 2023 | 22,314.00 |
| Jun 30, 2023 | 14,742.00 |
| Mar 31, 2023 | 10,244.00 |
| Dec 31, 2022 | 6,735.00 |
| Sep 30, 2022 | 6,249.00 |
| Jun 30, 2022 | 5,752.00 |
| Mar 31, 2022 | 3,731.00 |
| Dec 31, 2021 | 2,248.00 |
| Sep 30, 2021 | 1,269.00 |
| Jun 30, 2021 | 582.00 |
| Mar 31, 2021 | 800.00 |